Abstract:Increasing evidence suggests that malignant transformation can result from chronic infection, and Toll-like receptors (TLRs) may play an important role in this process. We have previously reported that the increased expression of TLR-9 is associated with tumor cell proliferation in oral cancer. However, the mechanisms involved have not been elucidated. The aim of this study was to investigate whether CpG-oligodeoxynucleotides (CpG-ODN), a special TLR-9 agonist, is able to exert the proliferation-promoting effect in human oral squamous cell carcinoma (OSCC), and to explore the possible underlying molecular mechanism. Flow cytometry, MTT, and colony formation assay were used to evaluate cell proliferation and cell cycle distribution. The mRNA and protein levels were analyzed by quantitative RT-PCR and Western blot assay. Luciferase reporter gene, EMSA, and ChIP assays were used to detect the activity of activator protein-1 (AP-1) and nuclear factor-κB (NF-κB) in HB cells. Results showed that CpG-ODN could stimulate proliferation of HB cells in a dose- and time-dependent manner with a promoted G(1) /S cell cycle progression. Increased cyclin D1 expression was detected in the nuclear region after CpG-ODN treatment. Moreover, CpG-ODN promoted nuclear translocation and activation of AP-1, which appeared to be required for TLR-9-mediated cyclin D1 expression and subsequently cell proliferation, but seemed to have little impact on NF-κB activity. Our results indicate that CpG-ODN stimulates tumor cell proliferation through TLR-9-mediated AP-1-activated cyclin D1 expression in OSCC HB cells. Pharmacologic inhibition of the TLR-9/AP-1/cyclin D1 pathway may be a new therapeutic approach for prevention as well as treatment of OSCC.

Activation of Toll-Like Receptor 3 Induces Apoptosis of Oral Squamous Carcinoma Cells in Vitro and in Vivo

Toll-like Receptor 3 and Tumor Immunity

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

Functional toll-like receptor 3 expressed by oral squamous cell carcinoma induced cell apoptosis and decreased migration.

Expression of TLR3 in Oral Squamous Carcinoma Cells and Induction of Apoptosis by Its Ligand Poly (I:C)

Toll-like receptors and cancer, particularly oral squamous cell carcinoma

Induction Of C-Myc-Dependent Cell Proliferation Through Toll-Like Receptor 3 In Head And Neck Cancer

Activation of Toll-Like Receptor-9 Promotes Cellular Migration Via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma

Poly I:C Enhances Cycloheximide-Induced Apoptosis of Tumor Cells Through TLR3 Pathway

The Functional Mechanisms of Toll-Like Receptor 3 and Its Implications in Digestive System Tumors.

Role of Toll-Like Receptor 4 on the Immune Escape of Human Oral Squamous Cell Carcinoma and Resistance of Cisplatin-Induced Apoptosis

Dose Dependent Activation of Retinoic Acid-Inducible Gene-I Promotes Both Proliferation and Apoptosis Signals in Human Head and Neck Squamous Cell Carcinoma.

Expression of Toll-like Receptor 3 in Head and Neck Squamous Cell Carcinoma and Its Significance

Increased Expression of Toll-like Receptor-9 Has Close Relation with Tumour Cell Proliferation in Oral Squamous Cell Carcinoma.

TLR3 Activation Inhibits Nasopharyngeal Carcinoma Metastasis Via Down-Regulation of Chemokine Receptor CXCR4

Expression of Survivin and Caspase 3 in Oral Squamous Cell Carcinoma and Peritumoral Tissue.

Toll-like Receptor 3 (TLR3) Induces Apoptosis Via Death Receptors and Mitochondria by Up-regulating the Transactivating P63 Isoform Α (Tap63α)

Toll-like Receptor-9 Agonists Increase Cyclin D1 Expression Partly Through Activation of Activator Protein-1 in Human Oral Squamous Cell Carcinoma Cells.

TLR9 Activation Induces Immunosuppression and Tumorigenesis Via PARP1/PD-L1 Signaling Pathway in Oral Squamous Cell Carcinoma.

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

Expression and role of methyltransferase 3 in oral malignant transformation